Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
2.580
-0.010 (-0.39%)
Nov 21, 2024, 2:13 PM EST - Market open
Leap Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 99 | 106 | 45 | 286 | 134 | 27 | |
| Market Cap Growth | 178.74% | 137.81% | -84.43% | 113.18% | 395.35% | -7.85% | |
| Enterprise Value | 37 | 26 | -33 | 162 | 77 | 18 | |
| Last Close Price | 2.59 | 4.14 | 4.50 | 32.40 | 22.50 | 11.20 | |
| PS Ratio | - | - | - | 190.77 | 89.49 | - | |
| PB Ratio | 2.02 | 1.76 | 0.76 | 2.65 | 2.88 | -15.49 | |
| P/TBV Ratio | 2.01 | 1.76 | 0.76 | 2.65 | 2.88 | - | |
| EV/Sales Ratio | - | - | - | 107.80 | 51.27 | - | |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | -0.59 | |
| Asset Turnover | - | - | - | 0.02 | 0.05 | - | |
| Quick Ratio | 3.95 | 5.63 | 6.02 | 11.63 | 7.07 | 0.48 | |
| Current Ratio | 3.97 | 5.64 | 6.05 | 11.70 | 7.09 | 0.50 | |
| Return on Equity (ROE) | -107.18% | -136.82% | -65.48% | -52.53% | -122.55% | -886.08% | |
| Return on Assets (ROA) | -58.05% | -75.03% | -36.33% | -29.17% | -57.24% | -157.03% | |
| Return on Capital (ROIC) | -70.64% | -89.56% | -40.73% | -32.30% | -76.13% | -492.77% | |
| Earnings Yield | -65.41% | -76.83% | -122.52% | -14.18% | -20.50% | -121.41% | |
| FCF Yield | -55.67% | -42.60% | -110.06% | -12.29% | -19.34% | -99.64% | |
| Buyback Yield / Dilution | -105.89% | -80.55% | -31.94% | -44.66% | -162.71% | -56.69% | |
| Total Shareholder Return | -105.89% | -80.55% | -31.94% | -44.66% | -162.71% | -56.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.